Literature DB >> 25217159

The microRNA biogenesis machinery modulates lineage commitment during αβ T cell development.

Levi J Rupp1, Brenna L Brady2, Andrea C Carpenter3, Maria Elena De Obaldia4, Avinash Bhandoola4, Remy Bosselut3, Stefan A Muljo5, Craig H Bassing6.   

Abstract

Differentiation of CD4(+) helper and CD8(+) cytotoxic αβ T cells from CD4(+)CD8(+) thymocytes involves upregulation of lineage-specifying transcription factors and transcriptional silencing of CD8 or CD4 coreceptors, respectively, in MHC class II or I (MHCII or I)-restricted thymocytes. In this study, we demonstrate that inactivation of the Dicer RNA endonuclease in murine thymocytes impairs initiation of Cd4 and Cd8 silencing, leading to development of positively selected MHCI- and MHCII-restricted mature CD4(+)CD8(+) thymocytes. Expression of the antiapoptotic BCL2 protein or inactivation of the p53 proapoptotic protein rescues these thymocytes from apoptosis, increasing their frequency and permitting accumulation of CD4(+)CD8(+) αβ T cells in the periphery. Dicer-deficient MHCI-restricted αβ T cells fail to normally silence Cd4 and display impaired induction of the CD8 lineage-specifying transcription factor Runx3, whereas Dicer-deficient MHCII-restricted αβ T cells show impaired Cd8 silencing and impaired induction of the CD4 lineage-specifying transcription factor Thpok. Finally, we show that the Drosha RNA endonuclease, which functions upstream of Dicer in microRNA biogenesis, also regulates Cd4 and Cd8 silencing. Our data demonstrate a previously dismissed function for the microRNA biogenesis machinery in regulating expression of lineage-specifying transcription factors and silencing of Cd4 and Cd8 during αβ T cell differentiation.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25217159      PMCID: PMC4185242          DOI: 10.4049/jimmunol.1401359

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  50 in total

1.  A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival.

Authors:  P P Lee; D R Fitzpatrick; C Beard; H K Jessup; S Lehar; K W Makar; M Pérez-Melgosa; M T Sweetser; M S Schlissel; S Nguyen; S R Cherry; J H Tsai; S M Tucker; W M Weaver; A Kelso; R Jaenisch; C B Wilson
Journal:  Immunity       Date:  2001-11       Impact factor: 31.745

Review 2.  Positive and negative selection of T cells.

Authors:  Timothy K Starr; Stephen C Jameson; Kristin A Hogquist
Journal:  Annu Rev Immunol       Date:  2002-10-16       Impact factor: 28.527

3.  Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development.

Authors:  Ichiro Taniuchi; Motomi Osato; Takeshi Egawa; Mary Jean Sunshine; Suk Chul Bae; Toshihisa Komori; Yoshiaki Ito; Dan R Littman
Journal:  Cell       Date:  2002-11-27       Impact factor: 41.582

Review 4.  Selection of the T-cell repertoire: receptor-controlled checkpoints in T-cell development.

Authors:  Harald von Boehmer
Journal:  Adv Immunol       Date:  2004       Impact factor: 3.543

5.  bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship.

Authors:  A Strasser; A W Harris; S Cory
Journal:  Cell       Date:  1991-11-29       Impact factor: 41.582

6.  CD8 coreceptor extinction in signaled CD4(+)CD8(+) thymocytes: coordinate roles for both transcriptional and posttranscriptional regulatory mechanisms in developing thymocytes.

Authors:  R Cibotti; A Bhandoola; T I Guinter; S O Sharrow; A Singer
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

7.  Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells.

Authors:  B H Koller; P Marrack; J W Kappler; O Smithies
Journal:  Science       Date:  1990-06-08       Impact factor: 47.728

8.  Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer.

Authors:  J Jonkers; R Meuwissen; H van der Gulden; H Peterse; M van der Valk; A Berns
Journal:  Nat Genet       Date:  2001-12       Impact factor: 38.330

9.  Runx3 and Runx1 are required for CD8 T cell development during thymopoiesis.

Authors:  Eilon Woolf; Cuiying Xiao; Ofer Fainaru; Joseph Lotem; Dalia Rosen; Varda Negreanu; Yael Bernstein; Dalia Goldenberg; Ori Brenner; Gideon Berke; Ditsa Levanon; Yoram Groner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-09       Impact factor: 11.205

10.  Negative selection of semimature CD4(+)8(-)HSA+ thymocytes requires the BH3-only protein Bim but is independent of death receptor signaling.

Authors:  Andreas Villunger; Vanessa S Marsden; Yifan Zhan; Miriam Erlacher; Andrew M Lew; Philippe Bouillet; Stuart Berzins; Dale I Godfrey; William R Heath; Andreas Strasser
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-26       Impact factor: 11.205

View more
  5 in total

Review 1.  Non-coding RNAs in CD8 T cell biology.

Authors:  Alexandria C Wells; Elena L Pobezinskaya; Leonid A Pobezinsky
Journal:  Mol Immunol       Date:  2020-02-18       Impact factor: 4.407

2.  miRNA-Processing Gene Methylation and Cancer Risk.

Authors:  Brian T Joyce; Yinan Zheng; Zhou Zhang; Lei Liu; Masha Kocherginsky; Robert Murphy; Chad J Achenbach; Jonah Musa; Firas Wehbe; Allan Just; Jincheng Shen; Pantel Vokonas; Joel Schwartz; Andrea A Baccarelli; Lifang Hou
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-02-23       Impact factor: 4.254

3.  microRNAs regulate cell-to-cell variability of endogenous target gene expression in developing mouse thymocytes.

Authors:  Rory Blevins; Ludovica Bruno; Thomas Carroll; James Elliott; Antoine Marcais; Christina Loh; Arnulf Hertweck; Azra Krek; Nikolaus Rajewsky; Chang-Zheng Chen; Amanda G Fisher; Matthias Merkenschlager
Journal:  PLoS Genet       Date:  2015-02-25       Impact factor: 5.917

Review 4.  The Clinical Application of MicroRNAs in Infectious Disease.

Authors:  Ruth E Drury; Daniel O'Connor; Andrew J Pollard
Journal:  Front Immunol       Date:  2017-09-25       Impact factor: 7.561

5.  Transcription Factor and miRNA Interplays Can Manifest the Survival of ccRCC Patients.

Authors:  Shijie Qin; Xuejia Shi; Canbiao Wang; Ping Jin; Fei Ma
Journal:  Cancers (Basel)       Date:  2019-10-28       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.